This presentation is intended to discuss US FDA’s Strategic Priorities – 2016 and Beyond.
Since 2009, there have been a lot of changes being implemented at the FDA. Understanding FDA’s strategic priorities for 2016 and beyond can help firms better understand and use the services or regulatory processes what the FDA offers.
It is believed that once the firms are familiar with FDA’s regulatory environment and strategic priorities, the firms can prioritize business goals and objectives in view of evolving regulatory science, regulatory plan/strategy including regulatory requirements for product approvals or clearances.
Based on new laws, statutes and new regulations, the FDA’s strategic priorities have evolved in implementing the statutory and regulatory requirements. It is imperative that the healthcare industry should understand FDA’s strategic priorities for the year 2016 and beyond so that industry can use the relevant and applicable information to better prioritize business processes in strategic response to the evolving regulatory environments.
This presentation by our expert speaker Dr. David Lim, Ph.D., RAC, ASQ-CQA will provide great opportunities to improve industry’s awareness for FDA’s strategic priorities for 2016 and beyond. Dr. Lim will share FDA’s various programs and strategic priorities for 2016 and beyond.
Why Should You Attend:
In this webinar, you will learn and understand the applicable regulatory requirements so that implementation of necessary regulatory requirements, if applicable, can be planned early and carried out in an effective and sustainable manner.
You will also get answers to the following tough questions:
Who should attend?
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). As a leading industry speaker, Dr. Lim frequently presents various topics in areas of FDA regulatory, clinical, quality and regulatory compliance matters in various forums and meetings.